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A 7-month-old New Forest foal presented for episodes of recumbency and stiﬀness with myotonic discharges on electromyography.
The observed phenotype resembled congenital myotonia caused by CLCN1 mutations in goats and humans. Mutation of the CLCN1
gene was considered as possible cause and mutation analysis was performed. The aﬀected foal was homozygous for a missense mutation
(c.1775A>C, p.D592A) located in a well conserved domain of the CLCN1 gene. The mutation showed a recessive mode of inheritance
within the reported pony family. Therefore, this CLCN1 polymorphism is considered to be a possible cause of congenital myotonia.
 2011 Elsevier B.V.
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Myotonias are acquired or inherited neuromuscular dis-
orders characterized by the slow relaxation of muscles after
voluntary contraction or electrical stimulation. Genetic
forms of congenital myotonia are characterized by
impaired function of chloride, sodium or potassium ion
transport channels in the skeletal muscle membrane [1–3].
It has been previously shown that sarcolemmal chloride
conduction is required to preserve membrane potential
and functional chloride channels are essential for resting
potential stabilization. Diﬀerent mutations in genes that0960-8966 2011 Elsevier B.V.
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muscular diseases [1,2,4,5]. Human congenital myotonia
is caused by recessive or dominant mutations of CLCN1
causing Becker’s (OMIM 255700) or Thomsen’s disease
(OMIM 160800). The muscle chloride channel CLCN1 reg-
ulates the electrical excitability of the skeletal muscle mem-
brane [1,2,6,7].
The association between myotonia and chloride conduc-
tion was ﬁrst described in myotonic mice [8] and the ﬁrst
mutation in the CLCN1 gene shown to cause myotonia
was found in domestic animals. The “fainting” goats which
developed severe acute muscle stiﬀness and became immo-
bile during vigorous movements or when startled showed a
missense mutation of the CLCN1 gene (p.A885P) [4]. In
1962 the ﬁrst case of suspected equine myotonia was
reported [7]. As the phenotype of the New Forest pony
reported here strongly resembled the clinical signs and
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we hypothesized that mutations in the CLCN1 gene might
also be responsible for the clinical signs observed in this
animal.
In this case study we report a missense mutation in the
equine CLCN1 gene associated with a recessive inherited
myotonia disease phenotype.Fig. 1B. Posture of the patient at rest. Note the straight angle of the
tarsus.2. Case report
A 7-month-old New Forest pony stallion was presented
to the Equine Clinic of Utrecht University. During the ﬁrst
4–6 weeks of life the foal had developed normally. Main
abnormalities observed by the owner were recurrent epi-
sodes of recumbency and diﬃculty rising to its feet as a
result of muscle stiﬀness. The frequency of these episodes
of recumbency had increased in the months prior to presen-
tation. At the time of clinical examination the foal was
found to be well developed with above average muscle
mass when compared to other foals of the same breed.
When stimulated (for example by opening of the stable
door or when getting up) the foal seemed hyperreactive
and temporary protrusion of the third eyelid occurred
due to retraction of the eye uni- or bilaterally (Fig. 1A).
During vocalization the whinnying ended in a high pitched
squeaking, or a deep growling noise. The pelvic limbs were
extremely straight (minimal ﬂexion of the tarsi) (Fig. 1B),
and the foal walked reluctantly with a stiﬀ gait. When
walking, the pelvic limbs did not always follow the track
of the thoracic limbs and the foal easily lost its balance
as a result of stiﬀness and occasionally lost its footing. Gen-
eral examination revealed no other abnormalities than
retraction of the eye and protrusion of the third eyelid
for approximately 30 s following inspection of the conjunc-
tiva. Neurological examination revealed normal mentation,
no cranial nerve deﬁcits and occasionally a wide-based
stance. Postural reactions were impossible to perform and
picking up the limbs was hampered by the muscle rigidity.Fig. 1A. Retraction of the eyebulb due to the myotonia. Note the
retracted eyebulb due to the myotonia.Manual ﬂexion of the proximal metacarpo/metatarso-pha-
langeal joints was impossible. Passive movements of the
neck and trunk were very limited and the foal was easily
pulled oﬀ balance. Although the foal showed signs of weak-
ness, ataxia was absent and the rigidity seemed to be the
major problem.
Blood biochemical analysis showed a plasma sodium
[Na] concentration of 129 mmol/l [ref. 135–150 mmol/l],
potassium [K] of 2.8 mmol/l [ref. 3.0–5.9 mmol/l], magne-
sium of 0.77 mmol/l [ref. 0.80–1.20 mmol/l], chloride [Cl]
of 99 mmol/l [ref. 96–107 mmol/l], total calcium [Ca] of
3.97 mmol/l [ref. 2.4–3.3 mmol/l] and phosphate of
1.48 mmol/l [[Pi]; ref. 0.8–1.8 mmol/l]. Blood obtained
immediately after an episode of generalized stiﬀness
revealed a [Na] of 138 mmol/l, a [K] of 4.1 mmol/l, a [Cl]
of 95 mmol/l and a plasma glucose concentration of
4.1 mmol/l (ref. 3.9–5.6 mmol/l). The fractional excretion
of all electrolytes in urine was within normal limits and
the acid–base balance of the blood was normal. Muscle
enzyme activities were not measured. DNA testing for
the mutation of the skeletal muscle sodium channel gene
(SCN4A) causing hyperkalemic periodic paralysis in Quar-
ter horses was negative. Electromyographic (EMG) needle
examination [9,10] using Viking Quest commercial EMG
equipment showed prolonged insertional activity caused
by spontaneous waxing and waning discharges after needle
insertion and as a result of muscle contraction in all mea-
sured muscles including the subclavian and descending pec-
toral muscle. The results of EMG examination were
consistent with myotonia [2,5,11,12] (Fig. 2).
Routine morphological (Gomori trichrome, H&E) and
histochemical analysis (succinic dehydrogenase, cyto-
chrome oxidase and m-ATPase) of biopsy samples from
the M. semimembranosus, M. gluteus medius, M. vastus
lateralis and M. triceps brachii caput longum were per-
formed. There was no evidence of muscle damage, rhabdo-
myolysis or central nuclei but extreme heterogeneity in
ﬁber diameters was noticed in all four muscle specimens
examined. In the caput longum of the M. triceps brachii
Fig. 2. (A) Myotonic discharges in the M. pectoralis descendens. (B) Myotonic discharges in the M. vastus lateralis. Dotted lines indicate the divisions,
one division is 200 lV and 100 ms in 2A and 500 lV and 200 ms in 2B. The ﬁring rate of the discharges is 72 Hz in 2A and 147 Hz in 2B.
Fig. 3. Histochemical staining of muscle sections from patient aﬀected by myotonia. Panel a. M. semimembranosus; panel b: M. gluteus medius; panel c:
M. vastus lateralis; panel d: M. triceps brachii Caput longum. Bar: 100 lm. Muscle samples were frozen in cold isopentane. Serial sections (10 lm) were cut
in a cryostat and stained for myoﬁbrillar adenosine triphosphatase (m-ATPase) after acid (pH 4.55) pre-incubation. Slow ﬁbers (type 1) are dark while
types 2A and 2 are light. Images were acquired with a bright ﬁeld microscope (Olympus Vanox AH-3, Japan), equipped with video camera and analyzed
with an image analysis software (Olympus DP-software-70).
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Fig. 4. Pedigree and sequence analysis of genomic DNA of the missense
mutation c.1775A>C in exon 15 of the equine CLCN1 gene of the case’s
family presented in this study. (A) Pedigree of the case’s family presented
in this study. DNA samples were available from numbered horses only.
The myotonic pony is shown in solid black box, the arrow indicated the
patient. The half black boxes are indicating the relatives heterozygous for
the mutation. (B) Sequence analysis of genomic DNA of the missense
mutation c.1775A>C in exon 15 of the equine CLCN1 gene. Sequence
chromatograms show the wildtype (1775AA; at the top), the carrier
(1775A/C; in the middle) and the mutated (1775CC; at the bottom)
individuals, respectively.
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ﬁrst consisted of ﬁbers with a diameter of 50.36 ± 9.3 lm,
whilst the second population (Fig. 3) consisted of ﬁbers
with a very small diameter, 20.21 + 8.8 lm.
We hypothesized that a mutation in the CLCN1 gene
may have been responsible for the clinical signs observed
in the present case [7]. The analysed pedigree data sug-
gested a monogenic autosomal recessive inheritance
(Fig. 4A). Parents of the aﬀected foal did not show any
clinical signs. EDTA blood samples of the aﬀected foal,
its dam, its sire, other related (n = 22) and unrelated
(n = 21) New Forest ponies, and 56 horses of various
breeds were examined (Supplementary Table 2). Genomic
DNA was isolated using standard methods. PCR primer
pairs were designed for the ampliﬁcation of CLCN1 exons
with ﬂanking introns (Table 1) as described previously [13].
The equine CLCN1 gene has 23 exons (NCBI Gene ID:
100050692), the total predicted transcript length is
2970 bp (Genbank acc. XM_001915636) encoding a pro-
tein of 989 aa (Genbank acc. XP_001915671). Initially,
all exons and several introns of the equine CLCN1 gene
were ampliﬁed using standard protocols applied to a total
of four DNA samples from the aﬀected foal, its dam, its
sire (Fig. 4A) and one unrelated control horse. The puriﬁed
PCR products were directly sequenced from both direc-
tions using the ABI BigDye v3.1 kit and an ABI 3730 cap-
illary sequencer (LifeTechnologies, Rotkreuz, Switzerland).
Sequence data were analysed using Sequencher 4.9 (Gene-
Codes, Ann Arbor, MI, USA).
A total of three polymorphisms were identiﬁed, two sin-
gle nucleotide substitutions in CLCN1 exon 15
(c.1593A>G and c.1775A>C) and a three base pair inser-
tion (c.2652_2653insCTT) in exon 23. No other mutations
in exonic or splice site regions of the CLCN1 gene were
identiﬁed. The c.1593A>G transition did not result in
amino acid exchange. The three family members (the foal
and its parents) were homozygous for the mutant allele
1593G and the unrelated control horse was homozygous
for the wildtype allele 1593A. This mutation was therefore
not associated with the disease. A similar genotype distri-
bution was observed for the in-frame insertion
(c.2652_2653insCTT) leading to an additional leucine resi-
due after codon 884 which aﬀects a less conserved protein
region. In conclusion, these two sequence variants are
highly unlikely to be related to the proper function of the
encoded protein.
Interestingly, the c.1775A>C transversion led to an
amino acid replacement where aspartic acid is replaced
by alanine (p.D592A). The aﬀected pony was homozygous
C/C for mutant allele1775C, the dam and the sire were het-
erozygous A/C and the control horse was homozygous A/
A for the wildtype allele 1775A (Fig. 4B).
To verify the association of the c.1775A>C mutation
with the clinical disease presentation an additional 42
New Forest ponies and 56 horses of 13 diﬀerent breeds
were screened using the methods described above (Supple-
mentary Table 2). None of the investigated animals washomozygous for the mutant allele 1775C. Of the genotyped
New Forest ponies eight mares (including the mother) and
one stallion (the sire of the aﬀected foal) were heterozygous
(A/C) for the mutant 1775C allele while all other horses
and ponies were homozygous A/A (Supplementary Table 2,
Fig. 4A).
To test whether the observed missense mutation aﬀects
CLCN1 splicing we ampliﬁed the entire CLCN1 cDNA
of the aﬀected foal. Total RNA extracted from four diﬀer-
ent skeletal muscles of the aﬀected pony was subjected to a
reverse transcription-PCR (RT-PCR) to analyse the
CLCN1 transcript. The entire coding sequence of 2970 bp
of the CLCN1 gene was ampliﬁed using ﬁve overlapping
Table 1
PCR primer pairs designed for the ampliﬁcation of CLCN1 exons with ﬂanking introns.
Primer name Forward primer sequence Reverse primer sequence bp C
PCR
CLCN1exon1 GGCTGTTCCTCAGGTTCTCA TCTCCAAGTGCACACTCAGC 604 60
CLCN1exon2 AGAACTTGGCGTCCTTGATG TAGGTGTGCATGTGGAGAGG 482 60
CLCN1exon3 CATCTTCTCACGTTGCCTTG CCTGGACCAGATTCACACCT 509 60
CLCN1exon4 + 5 GTGGCATCTTGTGAGGTGAA GGTCCACGTCTGCTCCTAGA 717 60
CLCN1exon6 AATGTTCCTCCATCGAATGC AGCACAAGAAGGCAATGTGG 463 60
CLCN1exon7 TGGCTTACCTGCCTTCCATA GAACAAGATCAGGCAAGTGGA 389 60
CLCN1exon8 GCCTGATCCTGACGTTCTGT CGTCTGCTCCACGACCTTAT 531 60
CLCN1exon9 + 10 GGTTGGAGCAAGGAAGGAAT CAGAGCATTCTGTCCACCAA 706 60
CLCN1exon11 + 12 TTGCAGGAGTTCAGTGTGGT AGGCTGTGGTCTCCAAGCTA 694 60
CLCN1exon13 + 14 GCTCCTCTCCTTGTTCTGGA GCTGGAATGAAGATGTCATGG 748 60
CLCN1exon15 + 16 CAATGTCACTCCTGTCACATCC TGGAACTCTTGTTCAGGTCACT 738 60
CLCN1exon17 + 18 CTGCTGAGTTGGCCAGAGG TATGGAGACTAAACAAATAGGAACC 846 60
CLCN1exon19 + 20 GAGGTGAGGCACCTAGGAAG CCTGCCTAGACTCGCATCTT 619 60
CLCN1exon21 + 22 GCGGATCTGAGGTTGAAGG CCAGGACTGTGGCCATAATAG 545 60
CLCN1exon23 GATGTGTGTGAGGAGGCCTTA GGTTAGAACCACCTGCGTGT 770 60
RT-PCR primers
CLCN1_cds_1 GAGCTGTATTGTGGGGAGGA AGGCCTTGAGGGTGAGGTAT 693 60
CLCN1_cds_2 CTGGGTCACCTTCCCACTTA GGATACAGCAGGAGGTGCTT 693 60
CLCN1_cds_3 AATGGATTTCCCCTTTGACC AAATTTGCTGAGCTGGTTCC 790 60
CLCN1_cds_4 CAGCCCTCCCTCTATGACAG CGTTGAATCCTGGGTTGTTT 657 60
CLCN1_cds_5 CCAAGACCCTCCATCTTTCA GGCCTCTTGACAGTCTGCAT 717 60
bp = product length; C = annealing temperature.
Fig. 5. Multiple sequence alignment of the CLCN1 protein in the region of the mutation demonstrates the conservation of aspartic acid residue 164
(D592) across species. The observed mutation in the myotonia aﬀected horse is indicated by an arrow and the respective position is highlighted in gray.
Identical residues are indicated by asterisks beneath the alignment. Genbank accession numbers of reference sequences: Equus caballus XP_001915671.1,
Canis lupus familiaris NP_001003124, Bos taurus DAA30294, Capra hircus AAC48666, Sus scrofa XP_003134618, Homo sapiens CAA80996, Mus
musculus NP_038519, Gallus gallus XP_425521, Danio rerio XP_695866. The position of the mutation associated with the congenital myotonia phenotype
is indicated. The alignment was calculated with ClustalW (http://www.ebi.ac.uk). Identical residues are indicated by asterisks beneath the alignment, while
colons and dots represent very similar and similar amino acids, respectively.
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from both directions as described above. No alterations
of the transcript could be observed apart from the poly-
morphisms detected at the genomic level.
3. Discussion
Myotonia is a primary skeletal muscle disease character-
ized by delayed relaxation of skeletal muscle after suddenforceful contraction, sometimes associated with clinical
signs of weakness. In humans, congenital myotonia, type
Thomsen [14] and generalized myotonia, type Becker [15]
are inherited as an autosomal dominant and recessive trait,
respectively [3]. Mutations of the CLCN1 gene have been
identiﬁed in adr/adr mice [8] and “fainting” goats [4]. Fur-
ther, CLCN1 animal models have been described in dogs.
Independent autosomal CLCN1 mutations, with a reces-
sive mode of transmission, cause myotonic phenotypes in
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[11]. The pony presented in this report demonstrated clini-
cal signs and EMG changes strikingly similar to those
observed in myotonic goats, supporting our assumption
that the disease phenotype in these two domestic species
might have been caused by independent CLCN1 gene
mutations [5,12]. Blood from the foal was examined for
the presence of mutations in the CLCN1 gene and found
to be homozygous for the missense mutation c.1755A>C
in exon 15. The associated CLCN1 mutation was probably
introduced by the grandfather of the aﬀected foal, as all
carriers identiﬁed so far could be traced back to this stal-
lion (Fig. 4A). This putative founder was the paternal
grandfather and the maternal grand-grandfather of the
aﬀected foal. Sequencing of unrelated controls of diﬀerent
breeds (Supplementary Table 2) showed that the CLCN1
c.1775A>C polymorphism was not present in other horses.
The fact that none of the examined horses unrelated to the
New Forest pony breed was shown to be carrier of the dis-
ease associated allele, indicates that this might be a quite
recent mutation, limited to a single breeding line which
has not yet spread into the general population. It is possible
that a spontaneous CLCN1 germline mutation occurred in
the assumed founder stallion.
The consequence of the c.1775A>C mutation was the
substitution of aspartic acid for alanine in codon 592 of
the C-terminal cytoplasmic domain of the equine CLCN1
protein. There was no indication that this mutation aﬀects
splicing of CLCN1. The aﬀected amino acid position is
highly conserved across mammalian orthologues (Fig. 5).
The human CLCN1 protein is enclosed by two related pro-
tein domains, the voltage gated chloride channel and the
CBS domain, respectively [17]. As CLCN1 functions as a
homooligomer, probably consisting of four subunits [17],
it is possible that the codon 592 mutation aﬀects the proper
formation of the functional ion channel. The potential
impact of this myotonia associated amino acid substitution
was evaluated by PolyPhen (http://genetics.bwh.har-
vard.edu/pph/). The substitution aﬀected a strongly con-
served residue and was predicted to be “probably
damaging” with a PSIC score diﬀerence of 2.25, which
implies that the substitution is very likely to aﬀect protein
function or structure. The deﬁciency of functional chloride
channels is a very plausible explanation for the observed
phenotype. The equine missense mutation seems to be per-
fectly associated with the condition even though it is
located distant to the causative CLCN1mutation described
in “fainting” goats [4,6,18].
The morphometric results resemble data reported for
human patients aﬀected by congenital myotonia: a selective
atrophy of type I ﬁbers has been observed in human skele-
tal muscles [19] together with muscle ﬁber hypertrophy [1].
However, breed and age diﬀerences do exist in muscle mor-
phology [20] and muscle tissue of other New forest ponies
was not available to strengthen these conclusions. Human
congenital myotonia has also been reported to be result
of a heterogeneous trait: apart from the association of con-genital myotonia with type I ﬁber atrophy, generalized
muscle ﬁber hypertrophy was observed in three quarters
of patients aﬀected by recessive myotonia, whereas the
remainder had normal muscle ﬁber size [1,21]. A moderate
hypertrophy of myotonic ﬁbers has previously been
reported in both myotonic goats, [22] and more recently
in myotonic dogs [23]. Muscle enzyme activities were not
available from this patient but are reported to vary from
normal to moderately elevated [2,11] and therefore do
not provide conclusive evidence.
In conclusion, this study reports the ﬁrst case of congen-
italmyotonia in horses for which themolecular genetic cause
was analyzed and which was associated with a missense
mutation of the equineCLCN1 gene. It illustrates the impor-
tance of precise clinical recognition of putative inherited dis-
eases and illustrates once again the value of the recently
deciphered horse genome sequence in unraveling the molec-
ular basis of such genetic anomalies. Our ﬁnding enables
direct genetic testing and the eradication of this genetic dis-
ease from the New Forest pony breeding population. Fur-
thermore, this study provides an additional genetically
characterized large animal model for human myotonia.
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